What is Rafael Holdings, Inc.'s infusion technology — D&A?

Rafael Holdings, Inc. (RFL) reported infusion technology — D&A of $44.25K in Q2 2025.

What does infusion technology — D&A mean?

Reflects the periodic expense recognized for the consumption of the Infusion Technology segment's capital assets and intangible assets. This metric helps investors distinguish between cash-based operating expenses and non-cash accounting charges. It is essential for calculating EBITDA and assessing the segment's capital intensity.

Rafael Holdings, Inc. RFL Infusion Technology — D&A

Similar metrics at other companies

DUOTTechnologies — D&A

$101.89K-38.0%

PHRTechnology Solutions Segment — D&A

$9.95M+44.7%

NVSTSpecialty Products & Technologies — D&A

$22.4M+8.7%

ZDTechnology & Shopping — D&A

$20.64M-7.9%

DDHealthcare & Water Technologies — D&A

$91M-1.1%

ABMTechnical Solutions — D&A

$2.6M+35.1%

Other financials

Income statement

See full

Revenue$179.0K-50.6%

Gross profit$131.0K-56.3%

Operating income-$6.9M-16.2%

Net income-$4.2M+11.6%

EPS (diluted)-$0.08+57.9%

Balance sheet

See full

Cash & equivalents$30.5M-19.6%

Total debt$21.9M+995%

Total equity$75.4M-6.4%

Total assets$92.0M-14.9%

Cash flow

See full

Operating cash flow-$7.3M-128%

CapEx$6.0K—

Free cash flow-$7.3M-128%

Valuation

See full

Market cap$170.56M+189%

P/S174×+93.5×

Profitability

See full

Gross margin71.9%—

Operating margin-3,717.2%+1,952pp

Net margin-2,117.2%-517pp

FCF margin-2,064.1%—

Returns & leverage

See full

Return on equity-26.6%-0.8pp

Debt / equity0.3×+0.2×

Current ratio3.2×-0.7×

Where this comes from

Reported directly by Rafael Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Rafael Holdings, Inc.’s 10-K, filed October 29, 2025, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s infusion technology — d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rafael Holdings, Inc.'s infusion technology — D&A?: Rafael Holdings, Inc. (RFL) reported infusion technology — D&A of $44.25K in Q2 2025.
What does infusion technology — D&A mean?: Reflects the periodic expense recognized for the consumption of the Infusion Technology segment's capital assets and intangible assets. This metric helps investors distinguish between cash-based operating expenses and non-cash accounting charges. It is essential for calculating EBITDA and assessing the segment's capital intensity.